Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Scientific Session

COVID-19

Meet the Panel: COVID-19

Sunday, November 12, 2023
11:00 AM – 11:45 AM PT
Location: Room 6A-B
On Demand In Person Livestreamed

    Panelist(s)

  • CC

    Cassandra Calabrese, DO

    Cleveland Clinic Foundation
    Cleveland Heights, OH, United States

    Disclosure(s): AstraZeneca: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Sanofi: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • MV

    Monica Verduzco-Gutierrez, MD

    University of Texas Health Science Center at San Antonio
    San Antonio, TX, United States

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Ipsen: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing); Merz: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • SL

    Susan Lee, MD

    UCSD
    SAN DIEGO, CA, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • ZW

    Zachary Wallace, MD, MSc

    Massachusetts General Hospital
    Newton, MA, United States

    Disclosure(s): BioCryst: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Terminated, April 1, 2023); Horizon: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); MedPace: Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, February 1, 2023); PPD: Consultant (Ongoing); Sanofi: Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Shionogi: Advisor or Review Panel Member (Terminated, May 1, 2022); Visterra: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Zenas: Advisor or Review Panel Member (Terminated, January 1, 2023), Consultant (Terminated, January 1, 2023)